Literature DB >> 15493068

EYA1 mutation in a newborn female presenting with cardiofacial syndrome.

N Shimasaki1, K Watanabe, M Hara, K Kosaki.   

Abstract

The combination of an asymmetric crying face and heart defect has been termed cardiofacial syndrome. This "syndrome" is etiologically heterogeneous and a subset of patients have 22q111.2 deletions. We present a female with Cayler's cardiofacial syndrome phenotype who had a frameshift mutation of the EYA1 gene. We conclude that EYA1 mutation represents a previously undescribed cause of cardiofacial syndrome.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15493068     DOI: 10.1007/s00246-003-0271-3

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  13 in total

1.  Importance of clinical evaluation and molecular testing in the branchio-oto-renal (BOR) syndrome and overlapping phenotypes.

Authors:  S Rickard; M Boxer; R Trompeter; M Bitner-Glindzicz
Journal:  J Med Genet       Date:  2000-08       Impact factor: 6.318

2.  New' manifestations of BOR syndrome.

Authors:  K M Weber; B G Kousseff
Journal:  Clin Genet       Date:  1999-10       Impact factor: 4.438

3.  Congenital hypoplasia of depressor anguli oris muscle. A genetically determined condition?

Authors:  C Papadatos; D Alexiou; D Nicolopoulos; H Mikropoulos; E Hadzigeorgiou
Journal:  Arch Dis Child       Date:  1974-12       Impact factor: 3.791

4.  Congenital hypoplasia of the depressor anguli oris muscle: differentiation from congenital facial palsy.

Authors:  K B Nelson; G D Eng
Journal:  J Pediatr       Date:  1972-07       Impact factor: 4.406

5.  Cardiofacial syndrome. Congenital heart disease and facial weakness, a hitherto unrecognized association.

Authors:  G G Cayler
Journal:  Arch Dis Child       Date:  1969-02       Impact factor: 3.791

6.  Cayler cardiofacial syndrome and del 22q11: part of the CATCH22 phenotype.

Authors:  A Giannotti; M C Digilio; B Marino; R Mingarelli; B Dallapiccola
Journal:  Am J Med Genet       Date:  1994-11-15

7.  BOR and BO syndromes are allelic defects of EYA1.

Authors:  C Vincent; V Kalatzis; S Abdelhak; H Chaib; S Compain; J Helias; F M Vaneecloo; C Petit
Journal:  Eur J Hum Genet       Date:  1997 Jul-Aug       Impact factor: 4.246

8.  Eya1-deficient mice lack ears and kidneys and show abnormal apoptosis of organ primordia.

Authors:  P X Xu; J Adams; H Peters; M C Brown; S Heaney; R Maas
Journal:  Nat Genet       Date:  1999-09       Impact factor: 38.330

9.  A human homologue of the Drosophila eyes absent gene underlies branchio-oto-renal (BOR) syndrome and identifies a novel gene family.

Authors:  S Abdelhak; V Kalatzis; R Heilig; S Compain; D Samson; C Vincent; D Weil; C Cruaud; I Sahly; M Leibovici; M Bitner-Glindzicz; M Francis; D Lacombe; J Vigneron; R Charachon; K Boven; P Bedbeder; N Van Regemorter; J Weissenbach; C Petit
Journal:  Nat Genet       Date:  1997-02       Impact factor: 38.330

10.  Hypoplasia or absence of the depressor anguli oris muscle and congenital abnormalities, with special reference to the cardiofacial syndrome.

Authors:  S E Levin; N H Silverman; S Milner
Journal:  S Afr Med J       Date:  1982-02-13
View more
  11 in total

Review 1.  The Eyes Absent proteins in development and disease.

Authors:  Emmanuel Tadjuidje; Rashmi S Hegde
Journal:  Cell Mol Life Sci       Date:  2012-09-13       Impact factor: 9.261

Review 2.  The EYA-SO/SIX complex in development and disease.

Authors:  Pin-Xian Xu
Journal:  Pediatr Nephrol       Date:  2012-07-19       Impact factor: 3.714

3.  A Tbx1-Six1/Eya1-Fgf8 genetic pathway controls mammalian cardiovascular and craniofacial morphogenesis.

Authors:  Chaoshe Guo; Ye Sun; Bin Zhou; Rosalyn M Adam; XiaoKun Li; William T Pu; Bernice E Morrow; Anne Moon; Xue Li
Journal:  J Clin Invest       Date:  2011-04       Impact factor: 14.808

4.  In Silico Analyses Reveal the Relationship Between SIX1/EYA1 Mutations and Conotruncal Heart Defects.

Authors:  Bojian Li; Lijuan Xu; Nanchao Hong; Sun Chen; Rang Xu
Journal:  Pediatr Cardiol       Date:  2017-10-17       Impact factor: 1.655

Review 5.  Friend or foe? Unraveling the complex roles of protein tyrosine phosphatases in cardiac disease and development.

Authors:  Maike Krenz
Journal:  Cell Signal       Date:  2022-03-05       Impact factor: 4.850

6.  A de novo and novel mutation in the EYA1 gene in a Chinese child with branchio-oto-renal syndrome.

Authors:  Guomin Li; Qian Shen; Li Sun; Haimei Liu; Yu An; Hong Xu
Journal:  Intractable Rare Dis Res       Date:  2018-02

7.  Identification of a novel nonsynonymous mutation of EYA1 disrupting splice site in a Korean patient with BOR syndrome.

Authors:  Hui Ram Kim; Mee Hyun Song; Min-A Kim; Ye-Ri Kim; Kyu-Yup Lee; Jong Kyung Sonn; Jaetae Lee; Jae Young Choi; Un-Kyung Kim
Journal:  Mol Biol Rep       Date:  2014-03-04       Impact factor: 2.316

8.  The EYA tyrosine phosphatase activity is pro-angiogenic and is inhibited by benzbromarone.

Authors:  Emmanuel Tadjuidje; Tim Sen Wang; Ram Naresh Pandey; Saulius Sumanas; Richard A Lang; Rashmi S Hegde
Journal:  PLoS One       Date:  2012-04-24       Impact factor: 3.240

Review 9.  The Eyes Absent proteins in development and in developmental disorders.

Authors:  Upendra Kumar Soni; Kaushik Roychoudhury; Rashmi S Hegde
Journal:  Biochem Soc Trans       Date:  2021-06-30       Impact factor: 5.407

10.  Copy number variants in Ebstein anomaly.

Authors:  Andreas Giannakou; Robert J Sicko; Wei Zhang; Paul Romitti; Marilyn L Browne; Michele Caggana; Lawrence C Brody; Laura Jelliffe-Pawlowski; Gary M Shaw; Denise M Kay; James L Mills
Journal:  PLoS One       Date:  2017-12-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.